Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Evolution of SARS-CoV-2 Shedding in Exhaled Breath Aerosols

Jianyu Lai, Kristen K. Coleman, S.-H. Sheldon Tai, Jennifer German, Filbert Hong, Barbara Albert, Yi Esparza, Aditya K. Srikakulapu, Maria Schanz, Isabel Sierra Maldonado, Molly Oertel, Naja Fadul, T. Louie Gold, Stuart Weston, Kristin Mullins, Kathleen M. McPhaul, Matthew Frieman, Donald K. Milton
doi: https://doi.org/10.1101/2022.07.27.22278121
Jianyu Lai
1Institute for Applied Environmental Health, University of Maryland School of Public Health, College Park, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristen K. Coleman
1Institute for Applied Environmental Health, University of Maryland School of Public Health, College Park, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S.-H. Sheldon Tai
1Institute for Applied Environmental Health, University of Maryland School of Public Health, College Park, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer German
1Institute for Applied Environmental Health, University of Maryland School of Public Health, College Park, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Filbert Hong
1Institute for Applied Environmental Health, University of Maryland School of Public Health, College Park, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barbara Albert
1Institute for Applied Environmental Health, University of Maryland School of Public Health, College Park, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yi Esparza
1Institute for Applied Environmental Health, University of Maryland School of Public Health, College Park, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aditya K. Srikakulapu
1Institute for Applied Environmental Health, University of Maryland School of Public Health, College Park, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Schanz
1Institute for Applied Environmental Health, University of Maryland School of Public Health, College Park, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isabel Sierra Maldonado
1Institute for Applied Environmental Health, University of Maryland School of Public Health, College Park, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Molly Oertel
1Institute for Applied Environmental Health, University of Maryland School of Public Health, College Park, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Naja Fadul
1Institute for Applied Environmental Health, University of Maryland School of Public Health, College Park, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T. Louie Gold
1Institute for Applied Environmental Health, University of Maryland School of Public Health, College Park, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stuart Weston
2Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristin Mullins
3Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathleen M. McPhaul
1Institute for Applied Environmental Health, University of Maryland School of Public Health, College Park, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Frieman
2Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Donald K. Milton
1Institute for Applied Environmental Health, University of Maryland School of Public Health, College Park, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dmilton@umd.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Aerosol inhalation is increasingly well recognized as a major if not primary mode of transmission of SARS-CoV-21,2. Over the course of the COVID-19 pandemic, three highly transmissible lineages evolved and became globally dominant3. One hypothesis to explain increased transmissibility is that natural selection favours variants with higher rates of viral aerosol shedding. However, the extent of aerosol shedding of successive SARS-CoV-2 variants is unknown. Here, we demonstrate that viral shedding (measured as RNA copies) into exhaled breath aerosol was significantly greater during infections with Alpha, Delta, and Omicron than with ancestral strains and variants not associated with increased transmissibility. The three highly transmissible variants independently evolved a high viral aerosol shedding phenotype, demonstrating convergent evolution. We did not observe statistically significant differences in rates of shedding between Alpha, Delta, and Omicron infections. The highest shedder in our study, however, had an Omicron infection and shed three orders of magnitude more viral RNA copies than the maximum observed for Delta and Alpha4. Our results also show that fully vaccinated and boosted individuals, when infected, can shed infectious SARS-CoV-2 via exhaled breath aerosols. These findings provide additional evidence that inhalation of infectious aerosols is the dominant mode of transmission and emphasize the importance of ventilation, filtration, and air disinfection to mitigate the pandemic and protect vulnerable populations. We anticipate that monitoring aerosol shedding from new SARS-CoV-2 variants and emerging pathogens will be an important component of future threat assessments and will help guide interventions to prevent transmission via inhalation exposure.

Competing Interest Statement

This work was supported by the Prometheus-UMD, sponsored by the Defense Advanced Research Projects Agency (DARPA) BTO under the auspices of Col. Matthew Hepburn through agreement N66001-18-2-4015, the National Institute of Allergy and Infectious Diseases Centers of Excellence for Influenza Research and Surveillance (CEIRS) Contract Number HHSN272201400008C, and the Centers for Disease Control and Prevention Contract Number 200-2020-09528. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position or policy of these funding agencies and no official endorsement should be inferred. This work was also supported by a grant from the Bill & Melinda Gates Foundation, and a generous gift from The Flu Lab (https://theflulab.org). The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript. D.K.M., Y.E, and B.A. received payments to their institution from Moderna, Inc., and Novavax, Inc., outside the submitted work. J.G. and M.S. received payments to their institution from Novavax, Inc., outside the submitted work. S.W. and M.F. received payments to their institution from National Institute of Allergy and Infectious Diseases (NIAID), Biomedical Advanced Research and Development Authority (BARDA), Defense Advanced Research Projects Agency (DARPA), Gates Foundation, Aikido Pharma, Emergent, Astrazeneca, Novavax, Regeneron, and the CDC, outside the submitted work. M. F. received royalties/licenses from Aikido Pharma for antiviral drug patent licensing, consulting fees from Aikido Pharma, Observatory Group, for consulting for COVID-19, and participation on Scientific Advisory Board for Aikido Pharma, outside the submitted work. None of the other authors have potential conflicting interests.

Funding Statement

This work was supported by the Prometheus-UMD, sponsored by the Defense Advanced Research Projects Agency (DARPA) BTO under the auspices of Col. Matthew Hepburn through agreement N66001-18-2-4015, the National Institute of Allergy and Infectious Diseases Centers of Excellence for Influenza Research and Surveillance (CEIRS) Contract Number HHSN272201400008C, and the Centers for Disease Control and Prevention Contract Number 200-2020-09528. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position or policy of these funding agencies and no official endorsement should be inferred. This work was also supported by a grant from the Bill & Melinda Gates Foundation, and a generous gift from The Flu Lab (https://theflulab.org). The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript. D.K.M., Y.E, and B.A. received payments to their institution from Moderna, Inc., and Novavax, Inc., outside the submitted work. J.G. and M.S. received payments to their institution from Novavax, Inc., outside the submitted work. S.W. and M.F. received payments to their institution from National Institute of Allergy and Infectious Diseases (NIAID), Biomedical Advanced Research and Development Authority (BARDA), Defense Advanced Research Projects Agency (DARPA), Gates Foundation, Aikido Pharma, Emergent, Astrazeneca, Novavax, Regeneron, and the CDC, outside the submitted work. M. F. received royalties/licenses from Aikido Pharma for antiviral drug patent licensing, consulting fees from Aikido Pharma, Observatory Group, for consulting for COVID-19, and participation on Scientific Advisory Board for Aikido Pharma, outside the submitted work. None of the other authors have potential conflicting interests.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The University of Maryland Institutional Review Board and the Human Research Protection Office of the Department of the Navy gave ethical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵* Co-first authorship

Data Availability

Deidentified data for the accepted manuscript will be made available on the Open Science Framework repository.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted July 29, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Evolution of SARS-CoV-2 Shedding in Exhaled Breath Aerosols
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Evolution of SARS-CoV-2 Shedding in Exhaled Breath Aerosols
Jianyu Lai, Kristen K. Coleman, S.-H. Sheldon Tai, Jennifer German, Filbert Hong, Barbara Albert, Yi Esparza, Aditya K. Srikakulapu, Maria Schanz, Isabel Sierra Maldonado, Molly Oertel, Naja Fadul, T. Louie Gold, Stuart Weston, Kristin Mullins, Kathleen M. McPhaul, Matthew Frieman, Donald K. Milton
medRxiv 2022.07.27.22278121; doi: https://doi.org/10.1101/2022.07.27.22278121
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Evolution of SARS-CoV-2 Shedding in Exhaled Breath Aerosols
Jianyu Lai, Kristen K. Coleman, S.-H. Sheldon Tai, Jennifer German, Filbert Hong, Barbara Albert, Yi Esparza, Aditya K. Srikakulapu, Maria Schanz, Isabel Sierra Maldonado, Molly Oertel, Naja Fadul, T. Louie Gold, Stuart Weston, Kristin Mullins, Kathleen M. McPhaul, Matthew Frieman, Donald K. Milton
medRxiv 2022.07.27.22278121; doi: https://doi.org/10.1101/2022.07.27.22278121

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (271)
  • Allergy and Immunology (557)
  • Anesthesia (135)
  • Cardiovascular Medicine (1769)
  • Dentistry and Oral Medicine (238)
  • Dermatology (173)
  • Emergency Medicine (316)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (662)
  • Epidemiology (10812)
  • Forensic Medicine (8)
  • Gastroenterology (594)
  • Genetic and Genomic Medicine (2960)
  • Geriatric Medicine (288)
  • Health Economics (534)
  • Health Informatics (1933)
  • Health Policy (836)
  • Health Systems and Quality Improvement (745)
  • Hematology (293)
  • HIV/AIDS (633)
  • Infectious Diseases (except HIV/AIDS) (12525)
  • Intensive Care and Critical Care Medicine (696)
  • Medical Education (300)
  • Medical Ethics (87)
  • Nephrology (324)
  • Neurology (2808)
  • Nursing (152)
  • Nutrition (433)
  • Obstetrics and Gynecology (559)
  • Occupational and Environmental Health (597)
  • Oncology (1473)
  • Ophthalmology (444)
  • Orthopedics (172)
  • Otolaryngology (257)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (381)
  • Pediatrics (868)
  • Pharmacology and Therapeutics (367)
  • Primary Care Research (338)
  • Psychiatry and Clinical Psychology (2646)
  • Public and Global Health (5383)
  • Radiology and Imaging (1016)
  • Rehabilitation Medicine and Physical Therapy (597)
  • Respiratory Medicine (727)
  • Rheumatology (330)
  • Sexual and Reproductive Health (290)
  • Sports Medicine (279)
  • Surgery (327)
  • Toxicology (48)
  • Transplantation (150)
  • Urology (126)